Parallax Volatility Advisers, L.P. Novo Nordisk A S Transaction History
Parallax Volatility Advisers, L.P.
- $35.7 Billion
- Q1 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 10,700 shares of NVO stock, worth $777,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,700
Previous 133,087
91.96%
Holding current value
$777,355
Previous $11.4 Million
93.51%
% of portfolio
0.0%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.37 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.07 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$900 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$895 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$862 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $164B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...